Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Solid Tumors × obinutuzumab × 1 year × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 42 Lymphoma, Follicular 23 Lymphoma, Non-Hodgkin 17 Lymphoma, Large B-Cell, Diffuse 12 Lymphoma 12 Lymphoma, Mantle-Cell 11 Lymphoma, B-Cell, Marginal Zone 11 Recurrence 8 Lymphoma, B-Cell 7 Neoplasms 6 Burkitt Lymphoma 5 Neoplasm, Residual 3 Leukemia, Hairy Cell 3 Leukemia, B-Cell 2 Leukemia 2 Waldenstrom Macroglobulinemia 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Prostatic Neoplasms 1 Part1: Advanced B-cell Malignancies 1 Ovarian Neoplasms 1 Mycosis Fungoides 1 Mesothelioma 1 Melanoma 1 Mature B-cell Malignancies 1 Lymphoma, T-Cell, Cutaneous 1 Lymphatic Diseases 1 Leukemia, Prolymphocytic 1 Hodgkin Disease 1

Interventions

pembrolizumab 5 Cetuximab 5 atezolizumab 3 spartalizumab 2 olaparib 2 fludarabine 2 Trastuzumab 2 Injections 2 Docetaxel 2 Cyclophosphamide 2 Bevacizumab 2 zolbetuximab 1 zimberelimab 1 zansecimab 1 tocilizumab 1 taxane 1 somatostatin receptor 2 1 ribociclib 1 pralsetinib 1 pertuzumab 1 pegylated granulocyte colony-stimulating factor 1 lenvatinib 1 ipatasertib 1 inavolisib 1 fludarabine phosphate 1 entrectinib 1 encorafenib 1 durvalumab 1 dapagliflozin 1 cemiplimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡